Table 1.
Study | (Number of patients) | Median survival time | (Months) |
---|---|---|---|
CA184-008 | (N = 155) | 10.2, 95% CI | (7.6–16.3) |
CA184-002 | (N = 217) | 11.4, 95% CI | (6.9–16.1) |
With 214 treated; n = 72 at 10 mg/kg | Ipilimumab + placebo (n = 57) | 19.3, 95% CI | (12.0–Not reached) |
CA184-007 (N = 115) | Ipilimumab + budesonide (n = 58) | 17.7, 95% CI | (6.8–Not reached) |